Correlation Between AstraZeneca PLC and Bristol Myers
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and Bristol Myers Squibb, you can compare the effects of market volatilities on AstraZeneca PLC and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Bristol Myers.
Diversification Opportunities for AstraZeneca PLC and Bristol Myers
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between AstraZeneca and Bristol is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Bristol Myers go up and down completely randomly.
Pair Corralation between AstraZeneca PLC and Bristol Myers
Considering the 90-day investment horizon AstraZeneca PLC ADR is expected to generate 0.83 times more return on investment than Bristol Myers. However, AstraZeneca PLC ADR is 1.21 times less risky than Bristol Myers. It trades about 0.36 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about -0.2 per unit of risk. If you would invest 6,586 in AstraZeneca PLC ADR on January 25, 2024 and sell it today you would earn a total of 534.00 from holding AstraZeneca PLC ADR or generate 8.11% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
AstraZeneca PLC ADR vs. Bristol Myers Squibb
Performance |
Timeline |
AstraZeneca PLC ADR |
Bristol Myers Squibb |
AstraZeneca PLC and Bristol Myers Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AstraZeneca PLC and Bristol Myers
The main advantage of trading using opposite AstraZeneca PLC and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.AstraZeneca PLC vs. Novartis AG ADR | AstraZeneca PLC vs. GlaxoSmithKline PLC ADR | AstraZeneca PLC vs. Roche Holding Ltd | AstraZeneca PLC vs. Bristol Myers Squibb |
Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |